Anafranil Related Published Studies
Well-designed clinical trials related to Anafranil (Clomipramine)
A double-blind, randomized, controlled trial of fluoxetine plus quetiapine or clomipramine versus fluoxetine plus placebo for obsessive-compulsive disorder. [2011.12]
Effect of aripiprazole augmentation of serotonin reuptake inhibitors or clomipramine in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study. [2011.04]
Quetiapine versus clomipramine in the augmentation of selective serotonin reuptake inhibitors for the treatment of obsessive-compulsive disorder: a randomized, open-label trial. [2010.03]
The clinical effect of clomipramine in chronic idiopathic pain disorder revisited using the Spielberger State Anxiety Symptom Scale (SSASS) as outcome scale. [2009.12]
Mid-term effects of serial sleep deprivation therapy implemented in cognitive-behavioral treatment on the neuroendocrine response to clomipramine in patients with major depression. [2009.04]
Placebo-controlled double-blind clomipramine trial for the treatment of anxiety or fear in beagles during ground transport. [2006.11]
Pulse-Loaded Intravenous Clomipramine in Treatment-Resistant Obsessive-Compulsive Disorder. [2006.02]
Study of the efficacy of fluoxetine and clomipramine in the treatment of premature ejaculation after opioid detoxification. [2006.01]
Antidepressant effects of different schedules of repetitive transcranial magnetic stimulation vs. clomipramine in patients with major depression: relationship to changes in cortical excitability. [2005.06]
Comparison of the efficacy of a synthetic dog-appeasing pheromone with clomipramine for the treatment of separation-related disorders in dogs. [2005.04.23]
Control of urine marking by use of long-term treatment with fluoxetine or clomipramine in cats. [2005.02.01]
Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. [2005.01]
Orthostatic side effects of clomipramine and moclobemide during treatment for depression. [2005]
Well-designed clinical trials possibly related to Anafranil (Clomipramine)
Non-antiepileptic drugs for trigeminal neuralgia. [2013]
Non-antiepileptic drugs for trigeminal neuralgia. [2011.01.19]
Efficacy of antidepressants for dysthymia: a meta-analysis of placebo-controlled
randomized trials. [2011]
Non-antiepileptic drugs for trigeminal neuralgia. [2011]
Harm avoidance as a mediator of treatment response to antidepressant treatment of patients with major depression. [2010]
Dimensional predictors of response to SRI pharmacotherapy in obsessive-compulsive
disorder. [2010]
Therapeutic alliance in short-term supportive and psychodynamic psychotherapies: a necessary but not sufficient condition for outcome? [2009.12.30]
Individual versus group cognitive-behavioral treatment for obsessive-compulsive disorder: a controlled pilot study. [2008.09]
Statistical choices can affect inferences about treatment efficacy: a case study from obsessive-compulsive disorder research. [2008.07]
A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder. [2008.05]
Pathophysiology and treatment of psychosis in Parkinson's disease: a review. [2008]
Sustained response versus relapse: the pharmacotherapeutic goal for obsessive-compulsive disorder. [2007.11]
The effectiveness of antidepressant medication in the management of behaviour problems in adults with intellectual disabilities: a systematic review. [2007.10]
Statistical choices can affect inferences about treatment efficacy: A case study from obsessive-compulsive disorder research. [2007.09.22]
Thirty cases of obsession treated by point-stimulation and with small dose of chlorimipramine. [2007.03]
Which panic disorder patients benefit from which treatment: cognitive therapy or antidepressants? [2007]
Non-antiepileptic drugs for trigeminal neuralgia. [2006.07.19]
Response versus remission in obsessive-compulsive disorder. [2006.02]
Serotonin modulation of cerebral blood flow measured with positron emission tomography (PET) in humans. [2005.03.15]
Standard criteria for relapse are needed in obsessive-compulsive disorder. [2005]
Treatment with medications affecting dopaminergic and serotonergic mechanisms: effects on fluency and anxiety in persons who stutter. [2005]
Other research related to Anafranil (Clomipramine)
NET occupancy by clomipramine and its active metabolite, desmethylclomipramine, in non-human primates in vivo. [2011.07]
Evaluation of the anxiolytic-like effects of clomipramine in two rat strains with different anxiety vulnerability (Wistar and Wistar-Kyoto rats): participation of 5-HT1A receptors. [2011.04]
Association study between genetic monoaminergic polymorphisms and OCD response to clomipramine treatment. [2011]
Antinociceptive interactions between Mu-opioid receptor agonists and the serotonin uptake inhibitor clomipramine in rhesus monkeys: role of Mu agonist efficacy. [2010.11]
Association of clomipramine and allopurinol for the treatment of the experimental infection with Trypanosoma cruzi. [2010.10]
Regional distribution of clomipramine and desmethylclomipramine in rat brain and peripheral organs on chronic clomipramine administration. [2010.08]
Clomipramine increases the incidence and duration of spike-wave discharges in freely moving WAG/Rij rats. [2010.06]
Pain sensitivity in major depression and its relationship to central serotoninergic function as reflected by the neuroendocrine response to clomipramine. [2009.12]
Clomipramine treatment reversed the glial pathology in a chronic unpredictable stress-induced rat model of depression. [2009.11]
Sex-related differential response to clomipramine treatment in a rat model of depression. [2009.11]
Recurrent vasovagal syncope: comparison between clomipramine and nitroglycerin as drug challenges during head-up tilt testing. [2009.09]
Serum cortisol concentration in patients with major depression after treatment with clomipramine. [2009.07]
Pancreatitis associated with clomipramine administration in a dog. [2009.02]
Correlation of plasma and peritoneal diasylate clomipramine concentration with hemodynamic recovery after intralipid infusion in rabbits. [2009.02]
Quetiapine versus clomipramine in the augmentation of selective serotonin reuptake inhibitors for the treatment of obsessive-compulsive disorder: a randomized, open-label trial. [2009.01.22]
Effect of neonatal clomipramine in the pathogenesis of ligature-induced periodontitis in Lewis rats. [2009]
Repeated clomipramine treatment reversed the inhibition of cell proliferation in adult hippocampus induced by chronic unpredictable stress. [2008.12]
A case of prolonged seizure after ECT in a patient treated with clomipramine, lithium, L-tryptophan, quetiapine, and thyroxine for major depression. [2008.12]
Effectiveness of long-term augmentation with citalopram to clomipramine in treatment-resistant OCD patients. [2008.11]
Mid-term effects of serial sleep deprivation therapy implemented in cognitive-behavioral treatment on the neuroendocrine response to clomipramine in patients with major depression. [2008.10.17]
Extrapyramidal side effects in a blue and gold macaw (Ara ararauna) treated with haloperidol and clomipramine. [2008.09]
Response to a combined treatment program with clomipramine, behavioral, and environmental management of compulsive tail chasing in a German Shepherd. [2008.09]
Intravenous augmentative citalopram versus clomipramine in partial/nonresponder depressed patients: a short-term, low dose, randomized, placebo-controlled study. [2008.08]
Forensic toxicological implication of an autopsy case of mixed drug overdose involving clomipramine, chlorpromazine and flunitrazepam. [2008.07]
Endoscopic removal of slow release clomipramine bezoars in two cases of acute poisoning. [2008.04]
Serotonin syndrome caused by olanzapine and clomipramine. [2008.01]
Comparative oxidative metabolic profiles of clomipramine in cats, rats and dogs: preliminary results from an in vitro study. [2007.10]
Reversible acute renal failure associated with clomipramine-induced interstitial nephritis. [2007.09]
Electroacupuncture combined with clomipramine enhances antidepressant effect in rodents. [2007.06.21]
A kinetic-pharmacodynamic model for clinical trial simulation of antidepressant action: application to clomipramine-lithium interaction. [2007.05]
Effects of physiological covariables on pharmacokinetic parameters of clomipramine in a large population of cats after a single oral administration. [2007.04]
[The influence of clomipramine on CYP2D6 activity] [2007.03]
Intralipid outperforms sodium bicarbonate in a rabbit model of clomipramine toxicity. [2007.02]
Age onset subtypes of obsessive compulsive disorder: differences in clinical response to treatment with clomipramine. [2007.02]
Treatment of compulsive sexual behaviour with clomipramine and valproic acid. [2007]
Voluntary exercise and clomipramine treatment elevate prepro-galanin mRNA levels in the locus coeruleus in rats. [2006.11.06]
A kinetic-pharmacodynamic model for clinical trial simulation of antidepressant action: Application to clomipramine-lithium interaction. [2006.09.19]
The effects of clomipramine hydrochloride in cats with psychogenic alopecia: a prospective study. [2006.09]
Pharmacokinetics of clomipramine and desmethylclomipramine after single-dose intravenous and oral administrations in cats. [2006.08]
Clomipramine and selegiline: do they influence impulse control? [2006.02]
Clomipramine-induced hypersensitivity syndrome with unusual clinical features. [2005.11]
Trypanosoma cruzi: chemotherapeutic effects of clomipramine in mice infected with an isolate obtained from an endemic area. [2005.10]
A fatal clomipramine intoxication case of a chronic alcoholic patient: application of postmortem hair analysis method of clomipramine and ethyl glucuronide using LC/APCI/MS. [2005.10]
Stressors affect the response of male and female rats to clomipramine in a model of behavioral despair (forced swim test). [2005.09.27]
Elevated thyroid indices in children and adolescents with obsessive-compulsive disorder: effects of clomipramine treatment. [2005.08]
Antidepressant effects of nicotine and fluoxetine in an animal model of depression induced by neonatal treatment with clomipramine. [2005.01]
Other possibly related research studies
Seizure Incidence in Psychopharmacological Clinical Trials: An Analysis of Food and Drug Administration (FDA) Summary Basis of Approval Reports. [2007.01.12]
Robust randomised control trials needed for drug treatments for trigeminal neuralgia. [2006]
Antidepressant treatment reduces Fos-like immunoreactivity induced by swim stress in different columns of the periaqueductal gray matter. [2006.10.16]
Therapeutic tricyclic antidepressant drug monitoring in younger and older depressive patients. [2006.07]
Premature ejaculation. [2006.08]
Tramadol for neuropathic pain. [2006.07.19]
Clinical features associated with treatment response in obsessive-compulsive disorder. [2006.07]
Molecular genetics and treatment of narcolepsy. [2006]
[Selective serotonin reuptake inhibitors (SSRIs) in pregnancy] [2006.04.12]
[Therapeutic drug monitoring: A pharmacotherapeutic tool in psychiatry] [2006.04.26]
Serotonin-norepinephrine reuptake inhibitors in the treatment of obsessive-compulsive disorder: A critical review. [2006.04]
Pharmacotherapy of obsessive-compulsive disorder and obsessive-compulsive spectrum disorders. [2006.06]
Female hormones affect symptom severity in obsessive-compulsive disorder. [2006.05]
Sexual pleasure in women with obsessive-compulsive disorder? [2006.03]
Shared obsessive-compulsive disorder. [2006]
[Clinical observation on effect of huoxue jieyu decoction in treating depression after craniotomy: a report of 45 cases] [2005.11]
Stereotypy II: a review of neurobiological interpretations and suggestions for an integration with behavioral methods. [2005.11]
Placental passage of tricyclic antidepressants. [2006.02.01]
Obsessions with aggressive content emerging during the course of panic disorder: a different subtype of obsessive-compulsive disorder? [2005.11]
Antidepressant drugs for narcolepsy. [2005.07.20]
Increased maintenance of obsessive-compulsive disorder remission after integrated serotonergic treatment and cognitive psychotherapy compared with medication alone. [2005]
|